This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2014 Sep;55(9):2207-8.

doi: 10.3109/10428194.2013.873538. Epub 2014 Jan 28.

Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis

Monica Maccaferri¹, Giovanna Leonardi, Roberto Marasca, Elisabetta Colaci, Ambra Paolini, Francesco Soci, Fabio Forghieri, Leonardo Potenza, Franco Narni, Mario Luppi

Affiliations

PMID: 24354678
DOI: 10.3109/10428194.2013.873538

Case Reports

Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis

Monica Maccaferri et al. Leuk Lymphoma. 2014 Sep.

. 2014 Sep;55(9):2207-8.

doi: 10.3109/10428194.2013.873538. Epub 2014 Jan 28.

Authors

Monica Maccaferri¹, Giovanna Leonardi, Roberto Marasca, Elisabetta Colaci, Ambra Paolini, Francesco Soci, Fabio Forghieri, Leonardo Potenza, Franco Narni, Mario Luppi

Affiliation

¹ Department of Medical and Surgical Sciences, UNIMORE, UO-C Ematologia, AOU Policlinico , Modena , Italy.

PMID: 24354678
DOI: 10.3109/10428194.2013.873538

No abstract available

PubMed Disclaimer

Similar articles

Extramedullary haematopoiesis within hepatic sinusoids of a patient with primary myelofibrosis.
Yamazaki K, Suzuki S, Kawaguchi T. Yamazaki K, et al. Br J Haematol. 2022 Mar;196(5):1130. doi: 10.1111/bjh.17923. Epub 2021 Nov 18. Br J Haematol. 2022. PMID: 34796484 No abstract available.
Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis.
Caocci G, Maccioni A, Murgia F, Perra A, Usai M, Piga M, Mascia R, La Nasa G. Caocci G, et al. Leuk Lymphoma. 2016 May;57(5):1215-8. doi: 10.3109/10428194.2015.1079320. Epub 2015 Oct 5. Leuk Lymphoma. 2016. PMID: 26308187 No abstract available.
Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients.
Bjørn ME, Holmström MO, Hasselbalch HC. Bjørn ME, et al. Leuk Lymphoma. 2016;57(1):125-8. doi: 10.3109/10428194.2015.1046867. Epub 2015 Sep 23. Leuk Lymphoma. 2016. PMID: 25936872
Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis.
Arana Yi C, Tam CS, Verstovsek S. Arana Yi C, et al. Future Oncol. 2015;11(5):719-33. doi: 10.2217/fon.14.272. Future Oncol. 2015. PMID: 25757677 Free PMC article. Review.
Ruxolitinib (Jakafi) for myelofibrosis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2012 Apr 2;54(1387):27-8. Med Lett Drugs Ther. 2012. PMID: 22469651 Review. No abstract available.

See all similar articles

Cited by

Case of Pulmonary Extramedullary Hematopoiesis Responding to Ruxolitinib.
Fujimoto A, Hamaguchi S, Suzuki R. Fujimoto A, et al. Leuk Res Rep. 2022 Feb 7;17:100290. doi: 10.1016/j.lrr.2022.100290. eCollection 2022. Leuk Res Rep. 2022. PMID: 35198370 Free PMC article.
Navigating 'grey areas' and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT.
Polverelli N, Hernández-Boluda JC, Gagelmann N, Gurnari C, Malagola M, Duarte FB, Funke VAM, Zerbi C, McLornan DP. Polverelli N, et al. Bone Marrow Transplant. 2025 Jan;60(1):10-18. doi: 10.1038/s41409-024-02437-6. Epub 2024 Oct 14. Bone Marrow Transplant. 2025. PMID: 39402189 Review.
The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib.
Tremblay D, Putra J, Vogel A, Winters A, Hoffman R, Schiano TD, Fiel MI, Mascarenhas JO. Tremblay D, et al. Case Rep Hematol. 2019 Jan 6;2019:3294046. doi: 10.1155/2019/3294046. eCollection 2019. Case Rep Hematol. 2019. PMID: 30723558 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations